Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

A Soft, Steerable Continuum Robot That Grows via Tip Extension.

Greer JD, Morimoto TK, Okamura AM, Hawkes EW.

Soft Robot. 2018 Oct 24. doi: 10.1089/soro.2018.0034. [Epub ahead of print]

PMID:
30339050
2.

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.

Grigg SE, Date P, Loh Z, Estacio O, Johnson DF, Hawkes EA, Grigg A.

Support Care Cancer. 2018 Sep 27. doi: 10.1007/s00520-018-4476-7. [Epub ahead of print]

PMID:
30259115
3.

Considerations for using Natalizumab treatment in patients with a history of choroidal melanoma.

Kaye AE, Hawkes ED, Gout II, El-Amir AN, Neffendorf JE.

Mult Scler Relat Disord. 2018 Sep 12;26:74-76. doi: 10.1016/j.msard.2018.09.012. [Epub ahead of print]

PMID:
30237107
4.

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.

Hawkes EA, Loh Z, Estacio O, Chong G, Ha FJ, Gilbertson M, Grigg A.

Br J Cancer. 2018 Aug;119(5):546-550. doi: 10.1038/s41416-018-0183-x. Epub 2018 Jul 23.

PMID:
30033446
5.

Toward the Design of Personalized Continuum Surgical Robots.

Morimoto TK, Greer JD, Hawkes EW, Hsieh MH, Okamura AM.

Ann Biomed Eng. 2018 Oct;46(10):1522-1533. doi: 10.1007/s10439-018-2062-2. Epub 2018 May 31.

PMID:
29855755
6.

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.

Gleeson M, Peckitt C, To YM, Edwards L, Oates J, Wotherspoon A, Attygalle AD, Zerizer I, Sharma B, Chua S, Begum R, Chau I, Johnson P, Ardeshna KM, Hawkes EA, Macheta MP, Collins GP, Radford J, Forbes A, Hart A, Montoto S, McKay P, Benstead K, Morley N, Kalakonda N, Hasan Y, Turner D, Cunningham D.

Lancet Haematol. 2018 May;5(5):e190-e200. doi: 10.1016/S2352-3026(18)30039-5.

7.

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.

Wight JC, Chong G, Grigg AP, Hawkes EA.

Blood Rev. 2018 Sep;32(5):400-415. doi: 10.1016/j.blre.2018.03.005. Epub 2018 Mar 26. Review.

PMID:
29605154
8.

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma.

Wight JC, Hawkes EA, Berlangieri SU, Khor R, Grigg AP.

Leuk Lymphoma. 2018 Mar 23:1-3. doi: 10.1080/10428194.2018.1452217. [Epub ahead of print] No abstract available.

PMID:
29569979
9.

Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study.

Loh Z, Estacio O, Grigg A, Holmes NE, Chong G, Hawkes EA.

Support Care Cancer. 2018 Sep;26(9):3083-3089. doi: 10.1007/s00520-018-4162-9. Epub 2018 Mar 21.

PMID:
29564624
10.

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.

Campbell R, Chong G, Hawkes EA.

J Clin Med. 2018 Mar 21;7(4). pii: E62. doi: 10.3390/jcm7040062. Review.

11.

Series Pneumatic Artificial Muscles (sPAMs) and Application to a Soft Continuum Robot.

Greer JD, Morimoto TK, Okamura AM, Hawkes EW.

IEEE Int Conf Robot Autom. 2017 May-Jun;2017:5503-5510. doi: 10.1109/ICRA.2017.7989648. Epub 2017 Jul 24.

12.

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy.

Estacio O, Loh Z, Baker A, Chong G, Grigg A, Churilov L, Hawkes EA.

Intern Med J. 2018 May;48(5):556-560. doi: 10.1111/imj.13712.

PMID:
29227565
13.

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.

Gleeson M, Peckitt C, Cunningham D, Gibb A, Hawkes EA, Back M, Yasar B, Foley K, Lee R, Dash J, Johnson H, O'Hara C, Wotherspoon A, Attygalle A, Menasce L, Shenjere P, Potter M, Ethell ME, Dearden C, Radford J, Chau I, Linton K.

Leuk Lymphoma. 2018 Jul;59(7):1586-1595. doi: 10.1080/10428194.2017.1393671. Epub 2017 Nov 9.

PMID:
29119842
14.

Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.

Opat S, Hawkes EA.

J Clin Oncol. 2017 Dec 20;35(36):4093-4094. doi: 10.1200/JCO.2017.75.4721. Epub 2017 Nov 3. No abstract available.

PMID:
29099632
15.

Compact, semi-passive beam steering prism array for solar concentrators.

Zheng C, Li Q, Rosengarten G, Hawkes E, Taylor RA.

Appl Opt. 2017 May 10;56(14):4158-4167. doi: 10.1364/AO.56.004158.

PMID:
29047549
16.

Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment.

Moorcraft SY, Jones T, Walker BA, Ladas G, Kalaitzaki E, Yuan L, Begum R, Eltahir Z, Wotherspoon A, Montero-Fernandez A, Teixeira Mendes LS, Gonzalez de Castro D, Wilson SH, Proszek P, To YM, Hawkes E, Roy A, Cunningham D, Rao S, Watkins D, Starling N, Bowcock AM, Chau I.

Oncotarget. 2017 Apr 11;8(39):64999-65008. doi: 10.18632/oncotarget.17048. eCollection 2017 Sep 12.

17.

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.

Gleeson M, Counsell N, Cunningham D, Chadwick N, Lawrie A, Hawkes EA, McMillan A, Ardeshna KM, Jack A, Smith P, Mouncey P, Pocock C, Radford JA, Davies J, Turner D, Kruger A, Johnson P, Gambell J, Linch D.

Ann Oncol. 2017 Oct 1;28(10):2511-2516. doi: 10.1093/annonc/mdx353.

18.

A randomized, fellow eye, comparison of keratometry, aberrometry, tear film, axial length and the anterior chamber depth after eye rubbing in non-keratoconic eyes.

Chervenkoff JV, Hawkes E, Ortiz G, Horney D, Nanavaty MA.

Eye Vis (Lond). 2017 Aug 14;4:19. doi: 10.1186/s40662-017-0084-8. eCollection 2017.

19.

Design of a Compact Actuation and Control System for Flexible Medical Robots.

Morimoto TK, Hawkes EW, Okamura AM.

IEEE Robot Autom Lett. 2017 Jul;2(3):1579-1585. doi: 10.1109/LRA.2017.2676240. Epub 2017 Mar 1.

20.

Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.

Kühnl A, Cunningham D, Counsell N, Hawkes EA, Qian W, Smith P, Chadwick N, Lawrie A, Mouncey P, Jack A, Pocock C, Ardeshna KM, Radford J, McMillan A, Davies J, Turner D, Kruger A, Johnson PW, Gambell J, Rosenwald A, Ott G, Horn H, Ziepert M, Pfreundschuh M, Linch D.

Ann Oncol. 2017 Jul 1;28(7):1540-1546. doi: 10.1093/annonc/mdx128.

21.

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Hawkes EA, Chong G, Grigg A.

J Clin Oncol. 2017 Jan 20;35(3):371-372. doi: 10.1200/JCO.2016.68.2047. Epub 2016 Oct 28. No abstract available.

PMID:
28095269
22.

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.

Tamjid B, Mckendrick J, Schwarer A, Doig R, James P, Hosking P, Hawkes EA.

Asia Pac J Clin Oncol. 2017 Jun;13(3):226-233. doi: 10.1111/ajco.12611. Epub 2016 Dec 22.

PMID:
28004881
23.

Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013.

Gleeson M, Hawkes EA, Peckitt C, Wotherspoon A, Attygalle A, Sharma B, Du Y, Ethell M, Potter M, Dearden C, Horwich A, Chau I, Cunningham D.

Leuk Lymphoma. 2017 Aug;58(8):1805-1813. doi: 10.1080/10428194.2016.1265114. Epub 2016 Dec 8.

PMID:
27931133
24.

Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.

Murphy C, Hawkes E, Chionh F, Chong G.

J Clin Pharm Ther. 2017 Feb;42(1):111-114. doi: 10.1111/jcpt.12472. Epub 2016 Oct 28.

PMID:
27790727
25.

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.

Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frodin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Watkins DJ.

Int J Cancer. 2017 Jan 15;140(2):431-439. doi: 10.1002/ijc.30453. Epub 2016 Oct 17.

26.

Fruit fly scale robots can hover longer with flapping wings than with spinning wings.

Hawkes EW, Lentink D.

J R Soc Interface. 2016 Oct;13(123). pii: 20160730.

27.

COOLAIR Antisense RNAs Form Evolutionarily Conserved Elaborate Secondary Structures.

Hawkes EJ, Hennelly SP, Novikova IV, Irwin JA, Dean C, Sanbonmatsu KY.

Cell Rep. 2016 Sep 20;16(12):3087-3096. doi: 10.1016/j.celrep.2016.08.045.

28.

Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.

Ku M, Chong G, Hawkes EA.

Blood Rev. 2017 Jan;31(1):23-35. doi: 10.1016/j.blre.2016.08.001. Epub 2016 Aug 12. Review.

PMID:
27568879
29.

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.

Gleeson M, Hawkes EA, Cunningham D, Chadwick N, Counsell N, Lawrie A, Jack A, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford J, McMillan A, Davies J, Turner D, Kruger A, Johnson PW, Gambell J, Linch D.

Br J Haematol. 2016 Nov;175(4):668-672. doi: 10.1111/bjh.14287. Epub 2016 Aug 1.

PMID:
27477167
30.

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.

Jalali A, Ha FJ, Chong G, Grigg A, Mckendrick J, Schwarer AP, Doig R, Hamid A, Hawkes EA.

Ann Hematol. 2016 Apr;95(5):809-16. doi: 10.1007/s00277-016-2611-4. Epub 2016 Feb 15.

PMID:
26878861
31.

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.

Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frödin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Mauro DJ, Watkins DJ.

J Natl Cancer Inst. 2015 Sep 23;107(12):djv258. doi: 10.1093/jnci/djv258. Print 2015 Dec.

PMID:
26405092
32.

Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma.

Gleeson M, Hawkes EA, Cunningham D, Jack A, Linch D.

J Clin Oncol. 2015 Oct 1;33(28):3215-6. doi: 10.1200/JCO.2014.60.6731. Epub 2015 Aug 10. No abstract available.

PMID:
26261254
33.

Treatment of metastatic colorectal cancer: focus on panitumumab.

Tay RY, Wong R, Hawkes EA.

Cancer Manag Res. 2015 Jun 24;7:189-98. doi: 10.2147/CMAR.S71821. eCollection 2015. Review.

34.

Programmed cell death-1 inhibition in lymphoma.

Hawkes EA, Grigg A, Chong G.

Lancet Oncol. 2015 May;16(5):e234-45. doi: 10.1016/S1470-2045(15)70103-8. Review.

PMID:
25943068
35.

Kestenbaum׳s capillary number test--a forgotten sign?

Hawkes ED, Neffendorf JE.

Mult Scler Relat Disord. 2014 Nov;3(6):735-7. doi: 10.1016/j.msard.2014.09.087. Epub 2014 Oct 7. No abstract available.

PMID:
25891554
36.

Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice.

Hawkes EA, Chong G, Grigg A.

J Clin Oncol. 2015 Apr 1;33(10):1219-20. doi: 10.1200/JCO.2014.60.0486. Epub 2015 Feb 17. No abstract available.

PMID:
25691672
37.

Stress distribution and contact area measurements of a gecko toe using a high-resolution tactile sensor.

Eason EV, Hawkes EW, Windheim M, Christensen DL, Libby T, Cutkosky MR.

Bioinspir Biomim. 2015 Feb 2;10(1):016013. doi: 10.1088/1748-3190/10/1/016013.

PMID:
25642752
38.

Human climbing with efficiently scaled gecko-inspired dry adhesives.

Hawkes EW, Eason EV, Christensen DL, Cutkosky MR.

J R Soc Interface. 2015 Jan 6;12(102):20140675. doi: 10.1098/rsif.2014.0675.

39.

Transmission of epi-alleles with MET1-dependent dense methylation in Arabidopsis thaliana.

Watson M, Hawkes E, Meyer P.

PLoS One. 2014 Aug 19;9(8):e105338. doi: 10.1371/journal.pone.0105338. eCollection 2014.

40.

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.

Barton S, Hawkes EA, Cunningham D, Peckitt C, Chua S, Wotherspoon A, Attygalle A, Horwich A, Potter M, Ethell M, Dearden C, Gleeson M, Chau I.

Eur J Haematol. 2015 Mar;94(3):219-26. doi: 10.1111/ejh.12416. Epub 2014 Aug 18.

PMID:
25039915
41.

ASPECCT: panitumumab versus cetuximab for colorectal cancer.

Hawkes EA, Wong R.

Lancet Oncol. 2014 Jul;15(8):e302-3. doi: 10.1016/S1470-2045(14)70269-4. No abstract available.

PMID:
24988927
42.

Design principles for efficient, repeated jumpgliding.

Desbiens AL, Pope MT, Christensen DL, Hawkes EW, Cutkosky MR.

Bioinspir Biomim. 2014 Jun;9(2):025009. doi: 10.1088/1748-3182/9/2/025009. Epub 2014 May 22.

PMID:
24851908
43.

GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.

Hawkes EA, Barton S, Cunningham D, Peckitt C, Chua S, Wotherspoon A, Horwich A, Potter M, Ethel M, Dearden C, Chau I.

Ann Hematol. 2014 May;93(5):827-34. doi: 10.1007/s00277-013-1930-y. Epub 2013 Oct 26.

PMID:
24158386
44.

Rare case of precursor B-cell acute lymphoblastic leukemia presenting as a solitary paraspinal mass alone.

Roy AC, Hawkes EA, Bardy P, Woo T, Ting K, Astill D, Stelios Karapetis C.

J Clin Oncol. 2013 Aug 1;31(22):e383-5. doi: 10.1200/JCO.2012.47.2308. Epub 2013 Jun 24. No abstract available.

PMID:
23796995
45.

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

Cunningham D, Hawkes EA, Jack A, Qian W, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford JA, McMillan A, Davies J, Turner D, Kruger A, Johnson P, Gambell J, Linch D.

Lancet. 2013 May 25;381(9880):1817-26. doi: 10.1016/S0140-6736(13)60313-X. Epub 2013 Apr 22.

46.

Feasibility of nanofluid-based optical filters.

Taylor RA, Otanicar TP, Herukerrupu Y, Bremond F, Rosengarten G, Hawkes ER, Jiang X, Coulombe S.

Appl Opt. 2013 Mar 1;52(7):1413-22. doi: 10.1364/AO.52.001413.

PMID:
23458793
47.

Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.

Boyda HN, Procyshyn RM, Pang CC, Hawkes E, Wong D, Jin CH, Honer WG, Barr AM.

PLoS One. 2013;8(1):e53459. doi: 10.1371/journal.pone.0053459. Epub 2013 Jan 9.

48.

Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Barton S, Hawkes EA, Wotherspoon A, Cunningham D.

Oncologist. 2012;17(12):1562-73. doi: 10.1634/theoncologist.2012-0218. Epub 2012 Oct 18. Review.

49.

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases.

Hawkes EA, Ladas G, Cunningham D, Nicholson AG, Wassilew K, Barbachano Y, Ratnayake G, Rao S, Chau I.

BMC Cancer. 2012 Aug 1;12:326. doi: 10.1186/1471-2407-12-326.

50.

Comment on: 'use of mini-monoka stents for punctal/canalicular stenosis'.

Smith H, Lee R, Hawkes E, Khandwala M.

Br J Ophthalmol. 2012 Oct;96(10):1349. Epub 2012 Jun 8. No abstract available.

PMID:
22685094

Supplemental Content

Loading ...
Support Center